In the current economic climate, Pharma companies are under growing pressure: companies have lost billions of dollars in annual revenue due to patents coming to an end, and have seen their market share eroded by cheaper generic drugs. As a result, some procurement organisations are facing severe
cost cutting measures.
Addressing these challenges is central to the role procurement plays within the business.
In light of this we surveyed 100 healthcare procurement professionals from companies across Europe to find out their opinions on topics such as how to measure performance within procurement, the level of visibility over risk in the supply chain and the biggest problems faced when entering new markets.
Please note: That all fields marked with an asterisk (*) are required.